Tag: <span>COVID-19</span>

Home / COVID-19
Post

Risk of post-COVID symptoms linked to body mass index in children

by Justin Jackson , Medical Xpress Credit: Unsplash/CC0 Public Domain A study by the University of Pennsylvania and researchers from 26 U.S. children’s hospitals has linked elevated body mass index (BMI) to a significantly higher risk of developing post-acute sequelae of SARS-CoV-2 infection (PASC) among children and young adults. The study revealed a 25.4% increased...

Post

Montelukast doesn’t cut time to COVID symptom relief, clinical trial finds

by Mary Van Beusekom, University of Minnesota Credit: JESHOOTS.com from Pexels A 14-day course of the oral anti-inflammatory drug montelukast didn’t shorten symptom duration in nonhospitalized US adults with mild or moderate COVID-19, finds a randomized controlled clinical trial published today in JAMA Network Open. The Accelerating COVID-19 Therapeutic Interventions and Vaccines-6 (ACTIV-6) Study Group and Investigators randomly assigned...

New study reveals long-term brainstem damage in COVID-19 survivors using advanced MRI scans
Post

New study reveals long-term brainstem damage in COVID-19 survivors using advanced MRI scans

Study: Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations. Image Credit: Silver Place/Shutterstock.com A recent study published in Brain performed ultrahigh field quantitative susceptibility mapping (QSM) of the brainstem in coronavirus disease 2019 (COVID-19) survivors post-hospitalization. Introduction Neuroradiological changes have been reported in hospitalized COVID-19 patients. Cerebral microhemorrhages, white matter hyperintensities, and encephalopathy are...

Post

Newly discovered COVID vaccine targets may last longer

Workflow for the generation of SARS-CoV-2-derived HLA I and HLA II immunopeptidome data. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-51959-6 Melbourne researchers have discovered more than 200 new vaccine target candidates from the COVID-19 virus, SARS-CoV-2, that could lead to the development of vaccines with a longer lasting broader immunity than existing vaccinations. In a paper published in the journal Nature...

Post

Understanding symptoms: Is it hay fever, COVID or something else?

Hay fever (also called allergic rhinitis) affects 24% of Australians. Symptoms include sneezing, a runny nose (which may feel blocked or stuffy) and itchy eyes. People can also experience an itchy nose, throat or ears. But COVID is still spreading, and other viruses can cause cold-like symptoms. So how do you know which one you’ve got? Remind me, how...

Post

Ultra-powered MRI scans show damage to brain’s ‘control center’ is behind long-lasting COVID-19 symptoms

3D projections of the QSM χ maps on the rendered brainstem ROI extracted from the FreeSurfer segmentation for the healthy control group and the COVID group. The COVID group shows increased χ in the brainstem, specifically in the Medulla and Pons (black arrows). Credit: University of Cambridge Damage to the brainstem—the brain’s ‘control center’—is behind...

Post

Long COVID symptoms found to be prevalent among health care workers

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, and University College London has found that 33.6% of surveyed health care workers in England report symptoms consistent with post-COVID syndrome (PCS), more commonly known as long COVID. Yet only 7.4% of respondents reported that they have received a formal...

Post

COVID-19 increases chronic fatigue risk

New research shows that COVID-19 survivors, especially older adults and non-hospitalized patients, are at an increased risk for chronic fatigue syndrome—underscoring the need for comprehensive care for vulnerable populations. Study: Risk of chronic fatigue syndrome after COVID-19: A retrospective cohort study of 3227281 patients. Image Credit: DimaBerlin / Shutterstock In a recent study published in the Journal of Infection...